Product Information
METHYLPHENIDATE ER(LA) 40 MG CP is a generic product labeled by Sandoz Inc., priced at $1.8537 per EA under NDC 00781238601. Its NADAC has been published 75 times since Apr 30, 2025.
FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the methylphenidate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Sandoz Inc.NDC
00781238601
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021284FDA Approved
6/5/2002
TE Code
AB1
On Market Since
11/24/2015
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(LA) 40 MG CP has been published 75 times since Apr 30, 2025, and over the history we have for it it has declined 29.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8537 per EA |
|---|---|
| All-time high | $2.8322 (Jan 14, 2026) |
| All-time low | $1.8537 (Sep 23, 2026) |
| 52-week high | $2.8322 |
| 52-week low | $1.8537 |
| Median price | $2.3572 |
| Average price | $2.3881 |
| Largest weekly change | +17.7% (Aug 20, 2025) |
| Weeks tracked | 75 |
| Tracking since | Apr 30, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylphenidate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(LA) 40 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 40 MG CP, manufactured by Sandoz Inc., is $1.8537 per EA (NDC 00781238601), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE ER(LA) 40 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 40 MG CP has declined 29.7%. It has been tracked across 75 weekly CMS publications since Apr 30, 2025.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 40 MG CP?
Since Apr 30, 2025, the NADAC for METHYLPHENIDATE ER(LA) 40 MG CP has ranged from a low of $1.8537 (Sep 23, 2026) to a high of $2.8322 (Jan 14, 2026), with a median of $2.3572 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 40 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(LA) 40 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER(LA) 40 MG CP?
METHYLPHENIDATE ER(LA) 40 MG CP (NDC 00781238601) is labeled by Sandoz Inc., and CMS classifies it as a generic product.